The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.
MarketWatch· Jaimy Lee· Jul 23, 2026 · 1:18 PM
The FDA is deciding whether seven peptides like BPC-157 and TB-500 can be legally compounded, potentially opening the door to broader use in Americans.
This is a summary. Read the complete story at MarketWatch below.
Read full article at MarketWatchRelated Stories
marketsabout 6 hours ago
I got a $499 body scan to see if I have cancer. Here’s what I learned.
Our healthcare system is designed to diagnose the presence or absence of disease, one organ at a time. That means people have no baseline against which to make broader lifestyle decisions.
MarketWatch
marketsabout 8 hours ago
‘The pain was excruciating’: A friend in her 80s fell down her basement stairs. Could it have been avoided?
“She developed pleural effusion — fluid between the lungs and ribs — compressing her lungs and making it hard for her to breathe.”
MarketWatch
marketsabout 8 hours ago
Go ahead and get that poetry degree. Republican law won’t prevent people with humanities majors from getting student loans.
The vast majority of bachelor’s and graduate degree programs pass new rules meant to hold colleges accountable
MarketWatch